Row breaks out over WHO trial casting doubt on remdesivir as Covid-19 drug

Row breaks out over WHO trial casting doubt on remdesivir as Covid-19 drug

A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving Covid-19.

Gilead remdesivir results mixed in moderate Covid-19 patients

Gilead remdesivir results mixed in moderate Covid-19 patients

Gilead Sciences Inc said on Monday its antiviral drug remdesivir had mixed results in a late stage study of people with moderate Covid-19, as patients given a five-day course of the treatment showed

Japan's Takeda Pharma says it is developing coronavirus drug

Japan's Takeda Pharma says it is developing coronavirus drug

Takeda Pharmaceutical Co said on Wednesday it was developing a drug for high-risk patients infected with the new coronavirus, joining several other drugmakers seeking to develop a treatment for an illness that has killed over 3,000 people.